Indicative Announcement on Convening the 2025 Annual General Meeting
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Indicative Announcement on Convening the 2025 Annual General Meeting
Filed with SSE · · 8 pages · Chinese
Release
Zhejiang Huahai Pharmaceutical Co., Ltd. on 6ix
Earlier from Zhejiang Huahai Pharmaceutical
- Announcement on Outline of Open Day for Investors
- Announcement on Changing Independent Directors and Adjusting Members of Special Committees of Board of Directors
- Announcement on Disclosure of the 2025 Annual Report by the Holding Subsidiary, Changxing Pharmaceutical Co., Ltd.
- Announcement on the Return of Raised Funds
- Announcement on Holding Open Day Activities for Investor
Later from Zhejiang Huahai Pharmaceutical
- Announcement on Cancellation of Account for Raised Funds
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Obtaining Approval for Drug Clinical Trials by Subsidiary
- Announcement on Release of Pledge and Re-pledge of Some Shares of Shareholders
Follow Zhejiang Huahai Pharmaceutical into a list and get an email when it puts out news.
Follow Zhejiang Huahai Pharmaceutical